Intended for healthcare professionals


Merck cleared in personal injury case against Vioxx

BMJ 2005; 331 doi: (Published 10 November 2005) Cite this as: BMJ 2005;331:1101
  1. Susan Mayor
  1. London

    The pharmaceutical company Merck has won a personal injury court case associated with its cyclo-oxygenase-2 inhibitor rofecoxib (Vioxx) in the United States, a jury ruled in Atlantic City last week. This is the second case to be brought against the drug giant out of more than 6000 claims expected from people or their relatives who say they were harmed by rofecoxib. Merck lost the first case.

    In the most recent case, the state court jury found by an eight to one vote that Vioxx had not caused Frederick Humeston, a 60 year old Idaho postal worker, to have a …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription